When cortical development goes wrong: Schizophrenia as a neurodevelopmental disease of microcircuits

Journal of Anatomy

Volumn 217, Issue 4, 2010, Pages 324-333

  Garey, Laurence ^a  

^a Centre for Psychiatric Neuroscience   (Sweden)

Author keywords

Cortex; Dendritic spines; Glutamatergic neurons; Microglia; Neurodevelopment; Post mortem; Schizophrenia

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; HLA DR ANTIGEN; KAINIC ACID RECEPTOR;

ARTICLE; BRAIN DEVELOPMENT; DENDRITIC SPINE; HUMAN; MACROGLIA; MICROGLIA; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SCHIZOPHRENIA;

ADULT; AGED; AGED, 80 AND OVER; ASTROCYTES; AUTOPSY; DENDRITES; FEMALE; HUMANS; MALE; MICROGLIA; MIDDLE AGED; NEOCORTEX; NEURONS; PYRAMIDAL CELLS; SCHIZOPHRENIA;

EID: 77956466815     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/j.1469-7580.2010.01231.x     Document Type: Article

References (85)

1. Akbarian S, Bunney WE, Potkin SG. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 1993, 50:169-177.
2. Amaral MD, Pozzo-Miller L. The dynamics of excitatory synapse formation on dendritic spines. Cellscience 2009, 5:19-25.
3. Andreasen NC, Smith MR, Jacoby CG. Ventricular enlargement in schizophrenia: definition and prevalence. Am J Psychiatry 1982, 139:292-296.
4. Benes FM, Paskevich PA, Davidson J. Synaptic rearrangements in medial prefrontal cortex of haloperidol-treated rats. Brain Res 1985, 348:15-20.
5. Benes FM, Todtenkopf MS, Taylor JB. A shift in tyrosine hydroxylase-immunoreactive varicosities (TH-IRv) from pyramidal (PN) to nonpyramidal (NP) neurons occurs in layer II of the anterior cingulate cortex of schizophrenics. Abstr Soc Neurosci 1995, 21:259.
6. Bennett M. Positive and negative symptoms in schizophrenia: the NMDA receptor hypofunction hypothesis, neuregulin/ErbB4 and synapse regression. Aust N Z J Psychiatry 2009, 43:711-721.
7. Bernstein HG, Steiner J, Bogerts B. Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy. Expert Rev Neurother 2009, 9:1059-1071.
8. Bhatt DH, Zhang S, Gan WB. Dendritic spine dynamics. Annu Rev Physiol 2009, 71:261-282.
9. Brodmann K. Vergleichende Lokalisationslehre der Grosshirnrinde in ihren Prinzipien dargestellt auf Grund des Zellenbaues 1909/2006, Leipzig, Barth 1909, Translated by LJ Garey as Brodmann's Localisation in the Cerebral Cortex, 3rd edn. New York: Springer 2006
10. Browning MD, Dudek EM, Rapier JL. Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics. Biol Psychiatry 1993, 34:529-535.
11. Cao QL, Yan XX, Luo XG. Prenatal development of parvalbumin immunoreactivity in the human striate cortex. Cereb Cortex 1996, 6:620-630.
12. Catalá I, Ferrer I, Galofré E. Decreased numbers of dendritic spines on cortical pyramidal neurons in dementia. A quantitative Golgi study on biopsy samples. Hum Neurobiol 1988, 6:255-259.
13. Connor JR, Diamond MC. A comparison of dendritic spine number and type on pyramidal neurons of the visual cortex of old adult rats from social or isolated environments. J Comp Neurol 1982, 2:10.
14. Crow TJ, Ball J, Bloom SR. Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry 1989, 46:1145-1150.
15. DeLisi LE, Goldin LR, Hamovit JR. A family study of the association of increased ventricular size with schizophrenia. Arch Gen Psychiatry 1986, 43:148-153.
16. Done DJ, Crow TJ, Johnstone EC. Childhood antecedents of schizophrenia and affective illness: social adjustments at age 7 and 11. Br Med J 1994, 309:699-703.
17. Dorph-Petersen KA, Delevich KM, Marcsisin MJ. Pyramidal neuron number in layer 3 of primary auditory cortex of subjects with schizophrenia. Brain Res 2009, 1285:42-57.
18. Falkai P, Bogerts B, Rozumek M. Limbic pathology in schizophrenia: the entorhinal region - a morphometric study. Biol Psychiatry 1988, 24:515-521.
19. Ferrer I, Fábregues I, Rairiz J. Decreased numbers of dendritic spines on cortical pyramidal neurons in human chronic alcoholism. Neurosci Lett 1986, 69:115-119.
20. Fonnum F. Glutamate: a neurotransmitter in mammalian brain. J Neurochem 1984, 42:1-11.
21. Frangou S, Murray RM. Imaging as a tool in exploring the neurodevelopment and genetics of schizophrenia. Brit Med Bull 1996, 52:587-596.
22. Garey LJ, Ong WY, Barnes TRE. Dendritic spine loss on pyramidal cells of temporal cortex in schizophrenia. Neuropathol Appl Neurobiol 1993, 19:186-187.
23. Garey LJ, Ong WY, Patel TS. Reduction in dendritic spine number on cortical pyramidal neurons in schizophrenia. Abstr Soc Neurosci 1995, 21:237.
24. Garey LJ, Ong WY, Patel TS. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 1998, 65:446-453.
25. Garey LJ, Von Bussmann KA, Hirsch SR. Decreased numerical density of kainate receptor-positive neurons in the orbitofrontal cortex of chronic schizophrenics. Exp Brain Res 2006, 173:234-242.
26. Gehrmann J, Matsumoto Y, Kreutzberg GW. Microglia: intrinsic immunoeffector cell of the human brain. Brain Res Rev 1993, 20:269-287.
27. Glantz LA, Lewis DA. Assessment of spine density on layer III pyramidal cells in the prefrontal cortex of schizophrenic subjects. Abstr Soc Neurosci 1995, 21:239.
28. Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000, 57:65-73.
29. el Hachimi KH, Foncin JF. Loss of dendritic spines in Alzheimer's disease. C R Acad Sci III 1990, 311:387-402.
30. van Haren NEM, Pol HEH, Schnack HG. Progressive brain volume loss in schizophrenia over the course of the illness: Evidence of maturational abnormalities in early adulthood. Biol Psychiatry 2008, 63:106-113.
31. Harrison PJ. On the neuropathology of schizophrenia and its dementia: neurodevelopmental, neurodegenerative, or both? Neurodegen 1995, 4:1-12.
32. Harrison PJ. Schizophrenia: a disorder of neuro-development. Curr Opin Neurobiol 1997, 7:285-289.
33. Harrison PJ, McLaughlin D, Kerwin RW. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. Lancet 1991, 337:450-452.
34. Harvey I, Ron MA, Du Boulay G. Reduction of cortical volume in schizophrenia on magnetic resonance imaging. Psychol Med 1993, 23:591-604.
35. Hill JJ, Hashimoto T, Lewis DA. Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 2006, 11:557-566.
36. Hirsch SR, Das I, Garey LJ. A pivotal role for glutamate in the pathogenesis of schizophrenia, and its cognitive dysfunction. Pharmacol Biochem Behav 1997, 56:797-802.
37. Honea RA, Meyer-Lindenberg A, Hobbs KB. Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings. Biol Psychiatry 2008, 63:465-474.
38. Huntley GW, Rogers SW, Moran T. Selective distribution of kainate receptor subunit immunoreactivity in monkey neocortex revealed by a monoclonal antibody that recognizes glutamate receptor subunits GluR5/6/7. J Neurosci 1993, 13:2965-2981.
39. Huttenlocher PR. Synaptic density in human frontal cortex: developmental changes and effects of aging. Brain Res 1979, 163:195-205.
40. Huttenlocher PR. Synapse elimination and plasticity in developing human cerebral cortex. Am J Ment Defic 1984, 88:488-496.
41. Huttenlocher PR, Dabholkar AS. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol 1997, 387:167-178.
42. Huttenlocher PR, de Courten C, Garey LJ. Synaptogenesis in human visual cortex - evidence for synapse elimination during normal development. Neurosci Lett 1982, 33:247-252.
43. Jacobs B, Driscoll L, Schall M. Life-span dendritic and spine changes in areas 10 and 18 of human cortex: a quantitative Golgi study. J Comp Neurol 1997, 386:661-680.
44. Johnstone EC, Crow TJ, Frith CD. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976, ii:924-926.
45. Keshavan MS, Anderson S, Pettegrew JW. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res 1994, 28:239-265.
46. Kim JS, Kornhuber HH, Schmid-Burgk W. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci Lett 1980, 20:379-382.
47. Kolluri N, Sun Z, Sampson AR. Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. Am J Psychiatry 2005, 162:1200-1202.
48. Leclercq P, Royston MC, Garey LJ. A positional analysis of a subset of cortical neurons in the frontal cortex of schizophrenic brains. Neuropathol Appl Neurobiol 1996, 22:164.
49. Leclerq PD, Garey LJ, Gentleman SM. An automated position analysis of parvalbumin-immunoreactive cells in the cerebral cortex in control and schizophrenic post-mortem brain. Schizophr Res 1998, 29:91.
50. Liddle PF, Friston KJ, Frith CD. Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry 1992, 160:179-186.
51. Luby ED, Cohen BD, Rosenbaum F. Study of a new schizophrenomimetic drug Sernyl. Arch Neurol Psychiatry 1959, 81:363-369.
52. Lund JS, Lund RD, Hendrickson AE. The origin of efferent pathways from the primary visual cortex, area 17, of the macaque monkey as shown by retrograde transport of horseradish peroxidase. J Comp Neurol 1975, 164:287-303.
53. Mehraein P, Yamada M, Tarnowska-Dziduszco E. Quantitative study on dendrites and dendritic spines in Alzheimer's disease and senile dementia. Adv Neurol 1975, 12:453-458.
54. Michel AE, Garey LJ. The development of dendritic spines in the human visual cortex. Hum Neurobiol 1984, 3:223-227.
55. Mirra SS, Heyman A, McKeel D. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486.
56. Mrzljak L, Uylings HB, Kostovic I. Prenatal development of neurons in the human prefrontal cortex. II. A quantitative Golgi study. J Comp Neurol 1992, 316:485-496.
57. Newman SJ, Gentleman SM. Microwave antigen retrieval in formaldehyde-fixed human brain tissue. Methods Mol Biol 1997, 72:145-152.
58. Ong WY, Garey LJ. Ultrastructural features of biopsied temporopolar cortex (area 38) in a case of schizophrenia. Schizophr Res 1993, 10:15-27.
59. Petralia RS, Wang YX, Wenthold RJ. The NMDA receptor subunits NR2A and NR2B show histological and ultrastructural localization patterns similar to those of NR1. J Neurosci 1994, 14:6102-6120.
60. Pfefferbaum A, Zipursky RB, Lim KO. Computed tomographic evidence for generalized sulcal and ventricular enlargement in schizophrenia. Arch Gen Psychiatry 1988, 45:633-640.
61. Prohovnik I, Dwork AJ, Kaufman MA. Alzheimer-type neuropathology in elderly schizophrenia patients. Schizophr Bull 1993, 19:805-816.
62. Radewicz K, Garey LJ, Gentleman SM. Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics. J Neuropathol Exp Neurol 2000, 59:137-150.
63. Raedler TJ, Knable MB, Weinberger DR. Schizophrenia as a developmental disorder of the cerebral cortex. Curr Opin Neurobiol 1998, 8:157-161.
64. Rakic P, Bourgeois JP, Goldman-Rakic PS. Synaptic development of the cerebral cortex: implications for learning, memory, and mental illness. Prog Brain Res 1994, 102:227-243.
65. Reveley AM, Reveley MA, Clifford CA. Cerebral ventricular size in twins discordant for schizophrenia. Lancet 1982, 1:540-541.
66. Ross CA, Pearlson GD. Schizophrenia, the heteromodal association cortex and development: potential for a neurogenetic approach. Trends Neurosci 1996, 19:171-176.
67. Scheibel ME, Lindsay RD, Tomiyasu U. Progressive dendritic changes in aging human cortex. Exp Neurol 1975, 47:392-403.
68. Selemon LD, Goldman-Rakic PS. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 1999, 45:17-25.
69. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 1995, 52:805-818.
70. Smiley JF, Williams SM, Szigeti K. Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex. J Comp Neurol 1992, 321:325-335.
71. Sommer H, Quandt J. Langzeitbehandlung mit Chlorpromazin im Tierexperiment. Fortschr Neurol Psychiatr 1970, 38:466-491.
72. Stevens JR, Casanova MF, Bigelow L. Gliosis and schizophrenia. Biol Psychiatry 1988, 24:727-729.
73. Streit WJ. The role of microglia in brain injury. Neurotoxicology 1996, 17:671-678.
74. Suddath RL, Casanova MF, Goldberg TE. Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study. Am J Psychiatry 1989, 146:464-472.
75. Sweet RA, Henteleff RA, Zhang W. Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharm 2009, 34:374-389.
76. Uranova NA, Orlovskaya DD, Apel K. Morphometric study of synaptic patterns in the rat caudate nucleus and hippocampus under haloperidol treatment. Synapse 1991, 7:253-259.
77. Vincent JP, Kartalovski B, Geneste P. Interaction of phencyclidine ('angel dust') with a specific receptor in rat brain membranes. Proc Natl Acad Sci U S A 1979, 76:4678-4682.
78. Von Bussmann KA, Rodway A, Gentleman SM. Decreased glutamate binding sites in the left orbitofrontal cortex of chronic schizophrenics. Schizophr Res 1996, 18:175.
79. Weinberger DR, Marenco S. Schizophrenia as a neurodevelopmental disorder. Schizophrenia 2003, 326-348. Hirsch SR, Weinberger DR. 2nd edn, eds, Hoboken, NJ, Wiley-Blackwell
80. Weinberger DR, Torrey EF, Neophytides AN. Lateral cerebral ventricular enlargement in chronic schizophrenia. Arch Gen Psychiatry 1979, 36:735-739.
81. Wierzba-Bobrowicz T, Lewandowska E, Lechowicz W. Quantitative analysis of activated microglia, ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics. Folia Neuropathol 2005, 43:81-89.
82. Yan XX, Garey LJ, Jen LS. Prenatal development of NADPH-diaphorase-reactive neurons in human frontal cortex. Cereb Cortex 1996, 6:737-745.
83. Yan XX, Cao QL, Luo XG. Prenatal development of calbindin D-28K in human visual cortex. Cereb Cortex 1997, 7:57-62.
84. Zipursky RB, Lim KO, Sullivan EV. Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry 1992, 49:195-205.
85. Zukin SR, Zukin RS. Specific [3H]phencyclidine binding in rat central nervous system. Proc Natl Acad Sci U S A 1979, 76:5372-5376.